Stocks were flat to start the day as investors anticipated a number of potentially market-moving events. Aside from a host of earnings updates, results...
Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that...
Investors were cautious going into the final trading session of this volatile week. In the previous two sessions, stocks erased Monday’s steep losses. The...
Drug and diagnostic technology businesses are what make up the biotech industry. Before they can be approved by the U.S. Food and Drug Administration,...